Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)

1. Executive Summary
 
2. Global In Vitro Diagnostics Market & Future Forecast
2.1 Global – In Vitro Diagnostics Market Share & Future Forecast
2.2 Global IVD Market, Market Share by Company
 
3. In Vitro Diagnostics Market Segment – Past, Present & Future Forecast
3.1 Molecular Diagnostics
3.2 Clinical Chemistry
3.3 Hematology
3.4 Immunoassay
3.5 Point of Care Testing
3.6 Microbiology
3.7 Histology/Cytology
3.8 Flow Cytometry
3.9 Blood Screening Typing
3.10 Coagulation
 
4. Geographical Segmentation
4.1 USA – In Vitro Diagnostics Market
4.2 Japan – In Vitro Diagnostics Market
4.3 Europe – In Vitro Diagnostics Market
4.4 India – In Vitro Diagnostics Market
4.5 China – In Vitro Diagnostics Market
4.6 Taiwan – In Vitro Diagnostics Market
 
5. Merger & Acquisitions
5.1 Mergers & Acquisitions Deals in the IVD Sector, 2009
5.2 Number of All Mergers & Acquisitions Deals in the IVD Sector, (2004 - 2008) 
5.3 Top Ten Mergers & Acquisitions Deals in the IVD Sector, 2008
5.4 Value of Disclosed Mergers & Acquisitions Deals in the IVD Sector, (2004 – 2008) 
 
6. Licensing By Ten IVD Majors
6.1 Number of In-Licensing Deals Announced, (2004 – 2008) 
6.2 Number of In-Licensing Deals announced in 2008 by Ten IVD Majors
6.3 Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies
6.4 In-Licensing Deals Announced in 2008 by Ten IVD Players
 
7. A Review of International IVD Regulations
7.1 GHTF and AHWP: Elements for a Regulatory System
7.2 More Emphasis on Environmental Topics
7.2.1 Instructions for Use and Other Labeling
7.3 Auditing: A Tool for Improving Processes
7.3.1 More Regulated Countries
7.4 Future Leadership and Outlook for the Next 15 Years
 
8. Key Drivers of Growth in Global IVD Market
8.1 Aging of the population
8.1.1 Population Aged 60 or Over: World and Development Regions, 1950 - 2050
8.1.2 Old-Age Dependency Ratio: Major Areas, 2009 and 2050
8.2 Personalized Medicine – The Future
8.3 Continued Expansion of Point Of Care Including Self Testing
8.3.1 Future of Point of Care Testing – The ‘Worried Well’
8.3.2 Theranostics – Companion Diagnostics
8.3.3 Hub and Spoke
8.3.4 Education
8.4 Pharmacogenetic Testing and New Types of Genetic Disease Screening Tests
 
9. Key Challenges In the Global In Vitro Diagnostics Market
9.1 Regulatory and Reimbursement Issues
9.1.1 Coverage Policies
9.2 Manufacturing Obstacles in IVD Product Development
9.2.1 Rise in Point of Care (POC) Technologies
9.2.2 Avoiding Too Much, Too Soon
9.2.3 Closely Considering Materials and Environment
 
10. Key Players in the Global IVD Market
10.1 Abbott Laboratories
10.2 Roche
10.3 biomerieux
10.4 Beckman Coulter
10.5 BD (Becton, Dickinson and Company) 
10.6 Sysmex
10.7 Siemens
10.8 Ortho Clinical Diagnostics

List of Figures:
 
Figure 2 1: Global – In Vitro Diagnostic Market (Billion US$), 2007 – 2009
Figure 2 2: Global – Forecast for In Vitro Diagnostics Market (Billion US$), 2010 – 2014
Figure 2 3: Global – Segments of In Vitro Diagnostics Market Share (Percent), 2007 – 2009
Figure 2 4: Global – Forecast for Segments of In Vitro Diagnostics Market Share (Percent), 2010 – 2014
Figure 2 5: Global – In Vitro Diagnostics Market Share of top 8 Companies (Sysmex, BioMerieux, OCD (J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens & Roche) (Percent), 2009
Figure 3 1: Global – Molecular Diagnostics Market (Billion US$), 2007 – 2009
Figure 3 2: Global – Forecast for Molecular Diagnostics Market (Billion US$), 2010 – 2014
Figure 3 3: Global – Clinical Chemistry Market (Billion US$), 2006 – 2009
Figure 3 4: Global – Forecast for Clinical Chemistry Market (Billion US$), 2010 – 2014
Figure 3 5: Global – Hematology Market (Billion US$), 2007 – 2009
Figure 3 6: Global – Forecast for Hematology Market (Billion US$), 2010 – 2014
Figure 3 7: Global – Immunoassay Market (Billion US$), 2006 – 2009
Figure 3 8: Global – Forecast for Immunoassay Market (Billion US$), 2010 – 2014
Figure 3 9: Global – Point of Care Testing Market (Billion US$), 2003, 2006 – 2009
Figure 3 10: Global – Forecast for Point of Care Testing Market (Billion US$), 2010 – 2014
Figure 3 11: Global – Microbiology Market (Billion US$), 2006 – 2009
Figure 3 12: Global – Forecast for Microbiology Market (Billion US$), 2010 – 2014
Figure 3 13: Global – Histology/Cytology Market (Billion US$), 2005 – 2009
Figure 3 14: Global – Forecast for Histology/Cytology Market (Billion US$), 2010 – 2014
Figure 3 15: Global – Flow Cytometry Market (Billion US$), 2007 – 2009
Figure 3 16: Global – Forecast for Flow Cytometry Market (Billion US$), 2010 – 2014
Figure 3 17: Global – Blood Screening Typing Market (Billion US$), 2006 – 2009
Figure 3 18: Global – Forecast for Blood Screening Typing Market (Billion US$), 2010 – 2014
Figure 3 19: Global – Coagulation Market (Billion US$), 2006 – 2009
Figure 3 20: Global – Forecast for Coagulation Market (Billion US$), 2010 – 2014
Figure 4 1: USA – In Vitro Diagnostics Market (Billion US$), 2002 – 2009
Figure 4 2: USA – Forecast for In Vitro Diagnostics Market (Billion US$), 2010 – 2012
Figure 4 3: Japan – In Vitro Diagnostics Market (Billion US$), 2002 – 2009
Figure 4 4: Japan – Forecast for In Vitro Diagnostics Market (Billion US$), 2010 – 2012
Figure 4 5: Europe – In Vitro Diagnostics Market (Billion US$), 2002 – 2009
Figure 4 6: Europe – Forecast for In Vitro Diagnostics Market (Billion US$), 2010 – 2012
Figure 4 7: India – In Vitro Diagnostics Market (Million US$), 1996 – 2009
Figure 4 8: India – Forecast for In Vitro Diagnostics Market (Million US$), 2010 – 2012
Figure 4 9: China – In Vitro Diagnostics Market (Million US$), 1995 – 2009
Figure 4 10: China – Forecast for In Vitro Diagnostics Market (Million US$), 2010 – 2012
Figure 4 11: Taiwan – In Vitro Diagnostics Market (Million US$), 2007 – 2009
Figure 4 12: Taiwan – Forecast for In Vitro Diagnostics Market (Million US$), 2010 – 2012
Figure 5 1: Global – Number of All Mergers & Acquisitions Deals in the In Vitro Diagnostics Sector, 2004 – 2008
Figure 5 2: Global – Value of Disclosed Mergers & Acquisitions Deals in the In Vitro Diagnostics Sector (Billion US$) 2004 – 2008
Figure 6 1: Global – Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies 2004 – 2008
Figure 6 2: Global – Number of In-Licensing Deals announced by Ten In Vitro Diagnostics Companies, 2008
Figure 6 3: Global – Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies, 2004 – 2008
Figure 8 1: Global – Population Aged 60 or Over: World and Development Regions, 1950, 1975, 2009, 2025 & 2050
Figure 8 2: Global – Old-Age Dependency Ratio: Major Areas, 2009 & 2050
 
List of Table:
 
Table 5 1: Global – Mergers & Acquisitions Deals in the In Vitro Diagnostics Sector, 2009
Table 5 2: Global – Top Ten Mergers & Acquisitions Deals in In Vitro Diagnostics Sector (Million US$), 2008
Table 6 1: Global – In-Licensing Deals Announced in 2008 by Ten IVD Players
Table 8 1: Global – Population Aged 60 or Over, 65 or Over and 80 Or Over By Sex (Thousands): World, Major Areas and Regions, 2009
Table 10 1: Abbott Laboratories – Key Financials (Million US$) 2007 – 2009
Table 10 2: Roche – Key Financials (Million US$) 2007 – 2009
Table 10 3: Biomerieux – Financials (Million US$) 2007 – 2009
Table 10 4: Beckman Coulter – Financials (Million US$) 2007 – 2009
Table 10 5: BD (Becton, Dickinson and Company) – Financials (Thousand US$) 2008 – 2009
Table 10 6: Sysmex – Financials (Million Yen) 2007 – 2009
Table 10 7: Siemens – Financials (Million Euros) 2008 – 2009